HCP consent collection for pharma companies

OptInsight helps pharmaceutical and life sciences companies build compliant, GDPR-aligned relationships with healthcare professionals by managing the entire opt-in and preference collection process through high-quality phone outreach. Designed for launch and commercial teams, OptInsight handles the outreach so your team doesn’t have to, with proven results: up to 50% e-consent rates from HCPs, giving you a verified, engagement-ready audience from day one.

What is HCP consent collection?

HCP consent collection is the process by which pharmaceutical and life sciences companies obtain explicit permission from healthcare professionals, such as doctors, pharmacists, and nurses, to contact them with medical, commercial, or educational communications. Before a pharma company can send an HCP emails, invitations to events, drug updates, or any other outreach, they must first have a documented record that the HCP has agreed to receive that type of content, through that specific channel.

HCP consent capture typically involves:

  • Preferred communication channels — email, phone, post, or instant messaging
  • Topics of interest — specific therapy areas or products
  • Frequency of contact — how often the HCP is comfortable being reached
  • Formal agreement — a digital approval or verbal opt-in, known as e-consent

Under GDPR and ePrivacy regulations, all marketing communications to HCPs must be built on a lawful basis of consent. Non-compliance can result in significant fines and reputational damage, making a high-quality HCP consent database the foundation of any successful digital engagement strategy.

The challenge
pharma companies face

Reaching HCPs and collecting quality consent at scale is harder than it looks.

01
Low digital
response rates

The f2f availability of doctors is declining significantly. Collecting consent via face-to-face is becoming more difficult, and doctors are making more use of digital channels.

02
Tightening compliance
requirements

Every interaction must be documented, compliant, and preference-driven. Regulatory requirements are only increasing.

03
Missing
infrastructure and capabilities

Pharma teams lack the specialist expertise and systems to collect quality consent efficiently at scale.

The result: incomplete databases, stalled campaigns, and missed engagement opportunities.

Our HCP consent collection approach

Our mission is to expand and optimize your contacts, reach and sales according to general data protection regulation (GDPR).

Enrich your customer database in four steps. We collect, adapt, verify and enrich profile information:

1

Step 1: Collect

Call contacts in order to gather new data and obtain user consent
2

Step 2: Adapt

Ask permission to check, update and add missing information
3

Step 3: Verify

Confirm opt-in or withdraw consent by e-mail (GDPR compliant) Contacts can change their consent preferences at any time
4

Step 4: Enrich

Enriched data is automatically stored in a secure customer database, which is accessible everywhere and ready to use

How pharma companies
collect HCP consent

Pharma companies use a range of channels to collect consent from HCPs. The most effective strategies combine multiple touchpoints with phone outreach playing a central role in converting HCPs who haven’t responded to digital channels.

  • Phone calls

    A trained representative speaks directly with the HCP, explains the consent process, captures preferences, and records verbal or digital agreement. Personal, effective, and consistently delivers the strongest consent rates.

  • Post / Direct mail

    An opt-in link or consent letter sent directly to the HCP. Low effort to deploy at scale, but dependent on the quality of existing contact data.

  • Field force (rep-triggered)

    Medical sales representatives collect consent face-to-face during HCP visits, via tablet or digital form. Highly trusted, but limited by rep coverage and the declining frequency of in-person visits.

  • Webinars & virtual events

    Consent is captured at registration or during the event. Effective for HCPs already engaged with the brand, but does not reach unconverted audiences.

  • Conferences & congresses

    Boost interactions or QR codes allow on-the-spot consent collection. High-quality touchpoints, but limited in reach and frequency.

  • HCP portals & product websites

    Consent collection embedded into platforms HCPs already use, reducing friction. Effective but requires technical integration.

  • Instant messaging (WhatsApp, SMS)

    Used in specific regions with strong results. Effective but requires technical integration and local compliance checks.

No single channel is sufficient on its own. An end-to-end consenting solution that combines multiple touchpoints including real-time digital consent capture and high-quality phone outreach is the most reliable way to build a complete, compliant HCP database.

50

%
HCP's opted in

60

%
Opt-out to opt-in conversion

30

%
Appointment planning up to 30% on first contact

50

%
Increase of HCP preferences

70

%
HCP records deduplication

Why pharma companies
choose OptInsight
for consent capture

  • High-educated and experienced call agents
  • Sophisticated call agency technology
  • Covering Europe and GCC countries
  • No basic scripting. A real dialogue based on your value proposition
  • High success rates and proven approach
  • Possibly supplemented with social media campaigns

Trusted by pharma organizations across Europe

Store and manage collected HCP consent with our platform

  • Personal data control at the level of individual HCPs
  • Detailed, real time capturing of opt-ins/opt-outs according to mandatory GDPR Data Processing Record and local regulations
  • Single point of truth for HCP data leading to higher data quality and less internal discussions about validity of the collected e-consent
  • Data quality algorithm by Match & Merge to reduce duplication & improve golden records
  • Seamless connections with your marketing channels (e.g web, e-detail, portal) and automated synchronized with all channels connected, resulting in no more manual labor plus less mistakes
  • Automated synchronization with widely used applications in pharma, such as Veeva & OCE
  • Consent & preference center for HCPs
  • Data insights based on internal and external resources
More information about our consent management solution
optinsight consent management solution software contact

We take care of your initial consent collection process by starting Healthcare Professional (HCP) engagement by phone

Download our factsheet
consent collection data care optinsight
Latest article

Learn how GDPR shapes consent requirements for pharma in Europe

Frequently Asked Questions
about consent collection

HCP consent collection is the process by which pharmaceutical and life sciences companies obtain explicit, documented permission from healthcare professionals such as doctors, pharmacists, and nurses before contacting them with promotional, medical, or educational communications. Under GDPR and ePrivacy regulations, this permission must be freely given, specific, informed, and unambiguous. Without a valid consent record, pharma companies cannot legally send digital communications to HCPs in Europe.

Real-time consented data capture means that every opt-in or opt-out from an HCP is immediately recorded and automatically synchronized across all connected systems including CRM platforms like Veeva and OCE, email platforms, and digital channels. Rather than manually updating consent records after the fact, changes are processed instantly the moment an HCP gives, updates, or withdraws their consent. The result is that your entire team always works from accurate, up-to-date, and compliant HCP data with no manual effort and no risk of acting on outdated consent.

Consent can be collected in many ways. A representative of the company can ask for consent during a visit or a meeting, an HCP can fill in a webform, consent can be obtained during a phone call, etc. Regardless of the channel used, it is important that the consent process is thorough, respectful, non-coercive and compliant with relevant regulations and standards.

These can be various channels such as the field force, digital channels such as socials media, websites, congresses, webinars but also paper letters. Most important is that you gain prior consent before you can use it in line of the purposes of consent.

Consent management is typically done by organizations who collect and use personal information. They can use tools such as consent management platforms (CMPs) to help obtain and manage consent from individuals, comply with data privacy regulations and provide detailed information about data collection practices. It is important that the organization has a clear understanding of their legal obligations under data privacy regulations and that they have appropriate processes in place to obtain and manage consent in compliance with those regulations.

Implementing a consent management solution is crucial for pharma and life sciences companies for several reasons:

  1. Regulatory Compliance: With stringent regulations like GDPR and CCPA, companies must ensure they have explicit consent from healthcare professionals (HCPs) before processing their data. Non-compliance can result in hefty fines and damage to the company’s reputation.
  2. Trust and Transparency: Building trust with HCPs is essential. A consent management solution ensures that HCPs have control over their data and how it is used, fostering a transparent relationship.
  3. Efficient Communication: Consent management solutions streamline the process of obtaining and managing consents, allowing companies to communicate more effectively with HCPs through preferred channels.
  4. Data Security: Protecting sensitive data is paramount. A robust consent management system ensures that data is securely stored and managed, reducing the risk of data breaches.
  5. Personalized Engagement: By understanding HCPs’ preferences and obtaining their consent, companies can deliver more personalized and relevant content, enhancing engagement and satisfaction.
  6. Operational Efficiency: Automating consent management reduces manual processes, saving time and resources while ensuring accuracy and compliance.

These factors highlight the urgency for pharma and life sciences companies to implement a consent management solution to maintain compliance, build trust, and improve overall communication with healthcare professionals.

It is the explicit permission of the owner of the individual data to use the personal data for certain purposes such as promotional communication

Typical requirements:

Freely Given: Consent must be given voluntarily, without any pressure or coercion. For example, users should not be disadvantaged if they choose not to give consent.

Informed: Individuals must be fully informed about the identity of the organization, the purpose of data processing, the type of data collected, and their right to withdraw consent. This information must be presented in clear and accessible language.

Specific: Consent must be specific to the purpose of data processing. If data is processed for multiple purposes, consent must be obtained for each one separately.

Unambiguous: Consent must be given through a clear affirmative action, such as ticking a box or clicking a button. Pre-checked boxes or implied consent are not allowed.

Consent management can seem like a big hassle and additional work that can be alleviated if there’s no consent management platform in place and the consent management process is just ignored, right?

Yes,

The solution benefits for you:

HCP Consent auditability: All Healthcare Professional (HCP)  opt-ins and opt-outs are automatically captured and verified in accordance with (local) data protection regulations related to consent. You do not need to rely solely on just checkboxes in other systems, such as CRM.

High scalability: Consent can now be easily collected using digital consent forms, which significantly reduces your reliance on sales representatives in the consent management process and enhances your outreach through digital channels.

Seamless connectivity: The process of consolidating and synchronizing HCP consent data between systems is now automated, minimizing manual input and reducing the potential for errors.

Improved data quality: Consent data is now always up to date, as it is stored in a central repository where incoming and outgoing consents are checked for duplicates. This ensures that each HCP record is accurate and up to date, minimizing it to one correct entry.

Drivers for these campaigns are knowing where your customer is, defining the channels where the customers resides to capture and collect optins, making appealing content to optin, designing easy consent forms that are compliant with data protection rules, having a central repository where all mutations are captured right, complete and timely.

Personal data, as defined under laws like GDPR, refers to any information that can directly or indirectly identify a living individual. This includes:

  • Direct Identifiers: Obvious information such as name, email address, phone number, or social security number.
  • Indirect Identifiers: Information that, when combined, could identify someone, like IP addresses, location data, or cookie identifiers.
  • Special Category Data: More sensitive information, such as health records, religious beliefs, political opinions, or genetic data.

Essentially, if a piece of data can identify a person, it’s considered personal data. Proper handling of such data is crucial for maintaining privacy and compliance with regulations.

Boost your HCP engagement for launching in Europe

The power of the combination

By combining Optinsight’s best-in-class consent management system, TSD’s strengths in personal outreach, and Sciential’s leading digital marketing expertise, this collaboration delivers a comprehensive, end-to-end solution that ensures maximum engagement with European HCPs.

Read more about omnichannel consent collection